High-grade serous (HGS) ovarian cancer research showed that SHMT1 can stimulate pro-oncogenic cytokine expression through sialic acid to promote tumor growth and progression (Gupta et al., 2017). This evidence concerns the gene SHMT1 and ovarian carcinoma.